XP-21279/Carbidopa

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameXP-21279/Carbidopa
Drug Alias NameXP-21279 and CarbidopaCarbidopa / XP-21279Carbidopa and XP-21279279/CD
ClassificationSmall molecules
Mechanisms of ActionDopamine receptors agonistsDOPA decarboxylase inhibitors
TargetsAromatic-L-amino-acid decarboxylaseDopamine receptors
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes XP-21279Carbidopa
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesArbor Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArbor Pharmaceuticals Llc
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A